Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Erythema
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Skin Manifestations » Erythema
Description
Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. MeSH
Hierarchy View
Subtype Terms (8)
Erythema Infectiosum
2 drugs (1 approved, 1 experimental)
Erythema Multiforme
3 approved drugs
Phase 3 Indicated Drugs (3)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (15)
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (51)
Arlington Center for Dermatology
Baumann Cosmetic & Research Institute
Dermatology Clinical Research Center of San Antonio
Dermatology Consulting Services, High Point NC
Michigan Center for Skin Care Research
Minnesota Clinical Study Center
Oregon Dermatology and Research Center
Oregon Medical Research Center
Palmetto Clinical Trial Services, LLC
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (24)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
